Cost-effectiveness analysis of baclofen and chlordiazepoxide in uncomplicated alcohol-withdrawal syndrome

Indian Journal of Pharmacology

Volumn 46, Issue 4, 2014, Pages 372-377

  Reddy, Vikram ^a   Girish, K ^a   Lakshmi, Pandit ^b   Vijendra, R ^a   Kumar, Ajay ^b   Harsha, R ^a  

^a Departments of Pharmacology   (India)

^b KEMPEGOWDA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Alcohol withdrawal syndrome; baclofen; chlordiazepoxide; clinical institute withdrawal assessment for alcohol; cost effectiveness analysis

Indexed keywords

BACLOF; BACLOFEN; CHLORDIAZEPOXIDE; LORAZEPAM; UNCLASSIFIED DRUG; ALCOHOL;

ADULT; ALCOHOL WITHDRAWAL; ARTICLE; BACKACHE; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; FEVER; HUMAN; INSOMNIA; LOOSE FECES; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; ADOLESCENT; AGED; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG ADMINISTRATION; ECONOMICS; FEMALE; MALE; MIDDLE AGED; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BACLOFEN; CHLORDIAZEPOXIDE; COST-BENEFIT ANALYSIS; DRUG ADMINISTRATION SCHEDULE; DRUG COSTS; ETHANOL; FEMALE; HUMANS; MALE; MIDDLE AGED; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84905564931     PISSN: 02537613     EISSN: 19983751     Source Type: Journal    
DOI: 10.4103/0253-7613.135947     Document Type: Article

References (23)

1. Room R, Babor T, Rehm J. Alcohol and public health. Lancet 2005;365:519-30.
2. Prasad R. Alcohol use on the rise in India. Lancet 2009;373:17-8.
3. Ranganathan TT. Alcohol Related Harm in India: A fact sheet. [Internet]. Available from : http://www.addiction india.org/images-ttkh/alcohol-related- harm-in-india-a-fact-sheet.pdf [Last accessed on 2013 Jun 09].
4. Global Status Report on Alcohol and Health 2011. India-Socioeconomic context [Internet]; 2011. P 222. Available from: http://www.who.int/substance- abuse/publications/global-alcohol-report/msbgsrsear.pdf [Last accessed on 2013 Jun 09].
5. Hartsell Z, Drost J, Wilkens JA, Budavari AI. Managing alcohol withdrawal in hospitalized patients. JAAPA 2007;20:20-5.
6. Bayard M, McIntyre J, Hill KR, Woodside J Jr. Alcohol withdrawal syndrome. Am Fam Physician 2004;69:1443-50.
7. Amato L, Minozzi S, Davoli M. Efficacy and safety of pharmacological interventions Figure 4: Box plot: Comparison of symptom-free days in baclofen and chlordiazepoxide study groups. Mann-Whitney test, U=305.5, P=0.018 (p is signifi cant) for the treatment of the Alcohol Withdrawal Syndrome, Cochrane Database of Systemic Reviews [Internet] 2011. Available from: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD008537.pub2/pdf [Last accessed on 2013 Jun 09].
8. Mayo-Smith MF. Pharmacological management of alcohol withdrawal: A meta-analysis and evidence-based practice guideline: American Society of Addiction Medicine Working Group on Pharmacological Management of Alcohol Withdrawal. JAMA 1997;278:144-51.
9. Williams D, Mcbride AJ. The drug treatment of alcohol withdrawal symptoms: A systemic review. Alcohol Alcohol 1998;33:103-15.
10. Ait-Daoud N, Malcolm RJ Jr, Johnson BA. An overview of medications for the treatment of alcohol withdrawal and alcohol dependence with an emphasis on the use of older and newer anticonvulsants. Addict Behav 2006;31:1628-49.
11. Myrick H, Anton RF. Treatment of alcohol withdrawal. Alcohol Health Res World 1998;22:38-43.
12. Longo LP, Johnson B. Addiction: Part I. Benzodiazepines-side effects, abuse risk and alternatives. Am Fam Physician 2000;61:2121-8.
13. Addolorato G, Leggio L, Abenavoli L, Agabio R, Caputo F, Capristo E, et al. Baclofen in the treatment of alcohol withdrawal syndrome: A comparative study vs. diazepam. Am J Med 2006;119:276.e13-8.
14. Liu J, Wang L. Baclofen for alcohol withdrawal. Cochrane Database of Systematic Reviews [Internet] 2011. Available from: http://onlinelibrary.wiley. com/doi/10.1002/14651858.CD008502/pdf [Last accessed on 2013 Jun 09].
15. Addolorato G, Caputo F, Capristo E, Domenicali M, Bernardi M, Janiri L, et al. Baclofen effi cacy in reducing alcohol craving and intake: A preliminary double-blind randomized controlled study. Alcohol Alcohol 2002;37:504-8.
16. Addolorato G, Leggio L, Ferrulli A, Cardone S, Vonghia L, Mirijello A, et al. Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: Randomized, double-blind controlled study. Lancet 2007;370:1915-22.
17. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: The revised Clinical Institute Withdrawal Assessment for Alcohol scale (CIWA-Ar). Br J Addict 1989;84:1353-7.
18. Chattopadhyay S. Cost of Illness of Diabetes Mellitus in Thailand. Economist, National Institute of Cholera and Enteric Diseases, Kolkata, India. The Asian Scholar [Internet] 2011:1-19. Available from: http://www. asianscholarship.org/asf/ejourn/articles/Chattopadhyay.pdf [Last accessed on 2013 Jun 09].
19. Minimum Wage Rate and Variable Dearness Allowance (VDA) by Ministry of Labour and Employment. Government of India [Internet] 2012. Available from: http://labour.nic.in/main/MinWages12-13.pdf [Last accessed on 2013 Jun 09].
20. Contreras-Hernández I, Mould-Quevedo JF, Torres-González R, Goycochea-Robles MV, Pacheco-Domínguez RL, Sánchez-García S, et al. Cost-effectiveness analysis for joint pain treatment in patients with osteoarthritis treated at the Instituto Mexicano del Seguro Social (IMSS): Comparison of nonsteroidal anti-infl ammatory drugs (NSAIDs) vs. cyclooxygenase-2 selective inhibitors. Cost Effect Res Allocat 2008;6:21.
21. Edejer TT, Baltussen R, Adam T, Hutubessy R, Acharya A, Evans DB, et al. World Health Organization Guide To Cost-Effective Analysis [Internet] 2003. Available from: http://www.who.int/choice/publications/p-2003-generalised-cea. pdf [Last accessed on 2013 Jun 09].
22. Kumar CN, Andrade C, Murthy P. A randomized, double-blind comparison of lorazepam and chlordiazepoxide in patients with uncomplicated alcohol withdrawal. J Stud Alcohol Drugs 2009;70:467-74.
23. Drummond MF, Sculpher MJ, Torrance GW, ÒBrien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. New York: Oxford university press; 2005. Ch 8, Economic evaluation using patient-level data. p. 254-8.